Big Deal?

After receiving a promotional email from Elsevier, DrugMonkey considers what constitutes a noteworthy change in a journal's impact factor at his blog this week. The email, he says, advertises that one of the publisher's many titles saw a 0.336 boost in its impact factor from 2010 to 2011.

"Is this a significant difference? Who gives a hoot if the IF [impact factor] goes up by 0.336?" DrugMonkey asks. "Is this in any way meaningful?"

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.